0R02VivoSim Labs, Inc.

LSE · GB · Healthcare · Biotechnology · vivosim.ai

0.2310USD-92.72%Mkt Cap: —P/E: —5d ago

VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and in…

Key Statistics

Company

Market Cap—

Enterprise Value2.08M $

Revenue (TTM)112.00K $

Gross Profit-4.21M $

Net Income (TTM)-12.34M $

Revenue/Share0.0340 USD

Last Price0.2310 USD

Fiscal Year EndMar 2026

MR QuarterJun 2026

Employees15

CountryGB

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA-0.19

EV/Revenue18.54

P/S—

P/B-0.31

EPS (TTM)-1.31

EPS (Forward)—

52W Range

0.23100% of range24.46

52W High24.46 USD

52W Low0.2310 USD

Profitability

Gross Margin0.00%

Oper. Margin-15327.78%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-343.10%

ROA-89.50%

Growth

Revenue Growth-51.40%

Earnings Growth—

Cash Flow & Leverage

Operating CF-10.10M $

CapEx (TTM)—

FCF Margin-6763.73%

FCF Yield—

Net Debt-1.35M $

Net Debt/EBITDA0.12

Balance Sheet

Debt/Equity—

Current Ratio1.70

Quick Ratio0.90

Book Value/Sh-0.7340 USD

Cash/Share0.1120 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Splits

Last Split0.083333:1

Split DateMar 21, 2025

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.115.89M

Float14.42M

Insiders2.67%

Institutions11.09%

Technical

SMA 501.230 (-81.2%)

SMA 2001.388 (-83.4%)

Beta1.45

S&P 52W Chg16.25%

Avg Vol (30d)6.87K

Avg Vol (10d)390

Technical Indicators

RSI (14)29.9

MACD-0.8333

MACD Signal-0.1985

MACD Hist.-0.6348

BB Upper12.39 USD

BB Middle6.102 USD

BB Lower-0.1863 USD

BB Width206.11%

ATR (14)1.378 USD

Vol Ratio (20d)2.30x

0R02VivoSim Labs, Inc.

Industry Peers

Key Statistics